16007 Ixekizumab demonstrated longer medication persistence than other biologics in the treatment of psoriasis patients: Results from IBM MarketScan databases
Blauvelt, Andrew, Leonardi, Craig L., Lebwohl, Mark, Zhu, Baojin, Malatestinic, William, Eastman, Joe Eastman, Guo, Jiaying, Shrom, David, Murage, Mwangi J., Burge, RusselVolume:
83
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2020.06.759
Date:
December, 2020
File:
PDF, 272 KB
2020